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Estrone and Estradiol Concentrations in Human Ovaries, 
Testes, and Adrenals During the First Two Years of 
Life* 
F R A N K B I D L I N G M A I E R , T I M M. S T R O M , H E L M U T H G. DÖRR, 
W O L F G A N G E I S E N M E N G E R , A N D D I E T R I C H K N O R R 
University of Bonn, Institute for Clinical Biochemistry (F.B.), Bonn; and the University of Munich, 
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Munich, West Germany 
A B S T R A C T . To determine the origin of estrogens in infant 
blood, we measured estrone (Ei) and estradiol (E2) in the gonads 
of 50 girls and 64 boys who died suddenly between birth and 2 
yr of age as well as in the adrenals of 18 of these infant girls and 
16 of the boys. In the adrenals, Ei [median, 2.8 ng/g (10.4 pmol/ 
g); range, 1.1-4.8 ng/g (4.1-17.8 pmol/g)] and E 2 [median, 3.0 
ng/g (10.9 pmol/g); range, 1.2-5.3 ng/g (4.4-19.5 pmol/g)] were 
found in similar concentrations and were independent of age 
and sex. In the gonads, E 2 was the major estrogen, but the 
concentrations differed markedly between the sexes; E 2 exceeded 
Ei almost 10-fold in the ovaries and 2-fold in the testes. On the 
average, the gonads of the infant girls had 5 times more E 2 and 
2 times more E! than those of the boys. As in plasma, E 2 
concentrations were highest in the ovaries of 1- to 6-month-old 
girls [median, 10.5 ng/g (38.5 pmol/g); range, 1.1-55.1 ng/g (4.0-
202.0 pmol/g)] and in testes of 1- to 3-month-old boys [median, 
1.8 ng/g (6.6 pmol/g); range, 0.6-6.4 ng/g (2.3-23.5 pmol/g)]. 
Ovarian E 2 concentrations declined to less than 3.0 ng/g (11.0 
pmol/g) by the end of the first year of life, and testicular E 2 
declined to less than 1.0 ng/g (3.7 pmol/g) after only 6 months 
of age. Gonadal estrogen concentrations paralleled changes in 
gonadal morphology. Ovarian weights varied in a pattern of rise 
and fall similar to that of ovarian E 2 concentrations; the biggest 
ovaries contained multiple macroscopic cysts. Testicular E 2 
closely correlated with Leydig cell development and testicular 
testosterone concentrations. We infer, therefore, that the surge 
of plasma E 2 in infant girls originates from ovarian follicles and 
that of boys from testicular Leydig cells, and that these both 
occur as a result of the postnatal surge in gonadotropin secretion. 
The basal plasma Ei and E 2 pool, however, is derived from the 
adrenals and remains at a comparatively constant level in both 
sexes. (J Clin Endocrinol Metab 65: 862, 1987) 
DU R I N G the first months after birth, the secretion of hypophyseal gonadotropins transiently in-
creases in infants in a sex-related manner (1). In boys, 
plasma L H and F S H concentrations increase steeply a 
few days after birth and by 1 month of age reach peak 
values comparable to those in adult men. They then 
decline rapidly and, by 4 months, reach levels character-
istic of normal childhood. The transient L H rise is fol-
lowed by striking elevations of testosterone in plasma 
(2) and testes (3); the plasma levels reach the lower adult 
range during the second or third month of life. In addi-
tion, plasma estradiol ( E 2 ) increases, although plasma 
estrone (Ei) changes little (4). In girls, there is a similar 
postnatal rise of gonadotropins. However, while L H lev-
els return to low values in girls at the same time as in 
boys, the rise in F S H levels is greater and more pro-
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Sigmund-Freud-Strasse 25, D-5300 Bonn 1, West Germany. 
* This work was supported by Grant Bi 306/1 from the Deutsche 
Forschungsgemeinschaft. 
longed, with the elevations lasting for 2-3 yr. Plasma E 2 
concentrations parallel the rise of F S H and can reach 
midpubertal levels during the third or fourth month, and 
the period of elevated E 2 lasts at least 1 yr. As in boys, 
plasma E i is low and varies little postnatally (4, 5). To 
determine the estrogen content of the different steroid-
producing glands in infancy and thus be able to make 
inferences about the source(s) of plasma E 2 and E i , we 
measured E 2 and E i concentrations in the gonads and 
adrenals of boys and girls up to 2 yr of age. 
Subjects and Methods 
Specimens 
Gonads were obtained postmortem from 50 girls and 64 boys 
who were previously healthy and who died of the sudden infant 
death syndrome or accident between birth and 2 yr of age. 
Premature and small-for-date infants or boys with undescended 
testes were excluded from the study. Both ovaries, but only 1 
testis, of a subject were analyzed. Adrenals obtained from 18 
female and 16 male infants were also studied. Many of the boys 
were identical to those from whom testes or adrenals were 
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taken for previous studies on androgen production (3, 6). The 
time interval between death and autopsy was 4-36 h. 
It is not certain whether the steroid content of gonads or 
adrenals removed postmortem is the same as that in normal 
glands in vivo. However, according to several reports (7, 8), 
changes in steroid composition in postmortem gonads or adre-
nals occur only very slowly. In preliminary experiments we 
found no change in the androgen and estrogen contents of an 
adrenal homogenate kept at room temperature from 12-36 h 
after death. Moreover, in this study we found no correlation 
between the steroid concentrations in glands from infants of 
the same age and the interval between death and autopsy, 
indicating that this interval did not alter the results. Thus, 
considering the difficulty in obtaining fresh glands from in-
fants, the use of autopsy material seems justified. 
Testes were separated from the epididymides; all glands were 
cleaned of adhering tissue, weighed, minced, and homogenized, 
as described previously (3, 6). Homogenates were stored at —80 
C until analyzed. The testicular weight was doubled to obtain 
the total weight per pair. 
Steroid determinations 
Ei and E 2 concentrations in tissue homogenates were deter-
mined in duplicate by RIA after chromatography on Sephadex 
LH-20 according to the method previously described for plasma 
(9). This method separated E i from E 2 , estriol, and other 
interfering steroids. Recovery of tritiated E i and E 2 added to 
each sample was between 60-75% and was taken into account 
in calculation of the results. The antiserum used for both E x 
and E 2 determinations had less than 0.05% cross-reactivity 
with dehydroepiandrosterone, androstenedione, testosterone, 
and all other nonphenolic steroids tested. The standard curves 
for Ei and E 2 ranged from 10-300 pg/tube (37-1100 fmol/tube). 
The sensitivity of the assays, defined as twice the SD of water 
blanks, was below 10 pg/mL (37 fmol/mL). Generally, 1 mL 
diluted (1:5 to 1:200) homogenate was introduced into the assay. 
The smallest steroid mass actually measured in the assays was 
38 pg (140 fmol) and, thus, was clearly distinguishable from 
zero. The interassay variability for the determination of E i and 
E 2 was 12% for pooled plasma (n = 12) and 19% for pooled 
gonadal and adrenal homogenates (n = 18). 
Statistics 
The data are expressed as the median and range for each age 
group. Differences between age groups were compared by the 
Kruskal-Wallis test (10). In two-sided tests, P < 0.05 was 
considered significant. 
Results 
The size of gonads and adrenals changed markedly 
during the first 2 yr of life. Paired ovarian weight (Fig. 
1) was lowest during the first month after birth (median, 
0.57 g/pair; range, 0.19-1.12 g/pair). It was highest (P < 
0.01) in 1- to 6-month-old girls (median, 1.41 g/pair; 
range, 0.36-4.2 g/pair), but then decreased and remained 
low to the end of the second year (median, 0.95 g/pair; 
range, 0.59-1.93 g/pair). Thus, the ovaries were largest 
during the period of increased gonadotropin secretion. 
Almost all ovaries contained visible cysts, which in some 
2- to 4-month-old girls were up to 5 mm in diameter. 
Testicular growth followed the pattern already de-
scribed in our previous study of a smaller number of boys 
(3). The mean testicular weight increased steadily from 
birth to 5 months from 0.55 to 1.41 g/pair and changed 
little thereafter. 
In contrast, mean adrenal weight in boys and girls 
decreased from 8.1 g/pair at birth to 4.3 g/pair by 5 
months of age. From then on, adrenal weight increased 
by the end of the second year of life, but did not reach 
neonatal values (6). 
Figure 2 shows ovarian estrogen concentrations, ex-
pressed as nanograms per g wet tissue, plotted against 
age. The age-related fluctuations of E 2 in the ovary 
resembled those in the plasma of healthy infants (4, 5). 
Maximum E 2 concentrations were found during the third 
and fourth months. In girls 1-6 months of age, ovarian 
E 2 concentrations [median, 10.5 ng/g (38.5 pmol/g); 
range, 1.1-55.1 ng/g (4.0-202.0 pmol/g)] were signifi-
cantly higher (P < 0.005) than in girls 6-24 months old 
[median, 2.4 ng/g (8.6 pmol/g); range, 1.4-22.1 ng/g (5.1-
81.1)]. On the average, 1 g ovarian tissue contained 400 
times more E 2 than 1 mL plasma (4, 5) from healthy 
girls of the same age. E i was also detectable in all ovaries. 
The concentrations were significantly higher (P < 0.01) 
during the first 6 months of life [median, 1.1 ng/g (4.1 
pmol/g); range, 0.3-4.4 ng/g (1.2-16.3 pmol/g)] than 
from 6-24 months [median, 0.6 ng/g (2.2 pmol/g); range, 
0.1-1.2 ng/g (0.4-4.6 pmol/g)]. On the average, E x was 
100 times higher in the ovaries than in the plasma (4, 5) 
of healthy girls of the same age. However, ovarian E i 
concentrations averaged only l/10th the concentrations 
of ovarian E 2 , with the exception of the first days after 
birth, when ovarian E i levels were at least half as high 
as E 2 levels. 
As in girls, the gonadal estrogen concentrations in 
boys (Fig. 3) showed age-dependent fluctuations similar 
to those in plasma. Testicular E 2 concentrations were 
highest in 1- to 3-month-old boys [median, 1.8 ng/g (6.6 
pmol/g); range, 0.6-6.4 ng/g (2.3-23.5 pmol/g)], de-
creased significantly (P < 0.01) in the group 3-6 months 
of age [median, 1.0 ng/g (3.7 pmol/g); range, 0.8-2.0 ng/ 
g (2.8-7.2 pmol/g)], and from then to the end of the 
second year were even lower (P < 0.005) than the levels 
in the preceding age group [median, 0.7 ng/g (2.4 pmol/ 
g); range, 0.4-1.4 ng/g (1.4-5.1 pmol/g)]. During the first 
2 yr of life, E 2 concentrations were about 100 times higher 
in the testes than in the plasma of normal boys (4, 5). 
E i concentrations in the testes averaged half of the E 2 
concentrations, and in only a few testes was E x equal to 
E 2 or the predominant estrogen. Testicular E i levels were 
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FIG. 1. Combined weight of paired ova- cc 
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highest in the 1- to 3-month-old group [median, 0.8 ng/ 
g (2.8 pmol/g); range, 0.3-2.1 ng/g (L2-7.7 pmol/g)], 
lower, though not significantly so between months 3 and 
6 [median, 0.6 ng/g (2.2 pmol/g); range, 0.2-1.3 ng/g 
(0.7-4.8 pmol/g)] and lowest (P < 0.02) after the age of 
6 months to the end of the second year [median, 0.3 ng/ 
g (1.2 pmol/g); range, 0.1-1.0 ng/g (0.3-3.7 pmol/g)]. On 
the average, testicular E i concentrations were 50 times 
those in plasma from normal boys (4, 5). 
When we compared testicular estrogen concentrations 
with the respective androgen levels, determined in a 
previous study (3), we found a closer correlation between 
E 2 and testosterone (P < 0.001) and between E i and 
androstenedione (P < 0.001) than between E x and tes-
tosterone (P < 0.05) of E 2 and androstenedione (P < 
0.05). Comparison of the estrogen concentrations in fe-
male and male gonads revealed roughly 5 times higher 
E 2 and 2 times higher E i concentrations in ovaries than 
in testes. 
Adrenal estrogen concentrations did not significantly 
change with age, and no significant sex difference was 
found. Therefore, the results were combined. For infants 
from birth to 2 yr of age, the respective estrogen concen-
trations in the adrenals were: E 2 : median, 3.0 ng/g (10.9 
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FIG. 3. Individual testicular estrone (O) 
and estradiol ( • ) concentrations in 
testes of infant boys plotted against age 
(nanograms per g wet tissue). Conver-
sion factors: Ei, ng/g x 3.699 = pmol/g; 
E 2 , ng/g X 3.671 = pmol/g. 
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pmol/g); range, 1.2-5.3 ng/g (4.4-19.5 pmol/g); and E x : 
median, 2.8 ng/g (10.4 pmol/g); range, 1.1-4.8 ng/g (4.1-
17.7 pmol/g; P = NS). The estrogen concentrations in 
the adrenals were 200-400 times higher than those in 
plasma and 2-3 times higher than those in testicular 
tissue; they were only exceeded by the E 2 concentrations 
in the ovaries during the first 6 months of life. 
Figure 4 compares the total estrogen content of adre-
nals and ovaries or testes, respectively, calculated from 
paired weights and tissue concentrations. Because the 
time pattern of gonadotropin secretion differs for male 
and female infants, the age groups were different for each 
sex. While the marked fluctuations in ovarian estrogen 
content are due to changes in both organ weight and 
tissue concentrations, the fluctuations in adrenal estro-
gen content merely reflect the remarkable changes in 
adrenal weight caused by the rapid postnatal involution 
of the fetal zone and the slow growth of the definitive 
zone of the adrenal cortex. 
Discussion 
Although measuring the glandular hormone concen-
tration does not necessarily indicate how much each 
gland contributes to hormone production, our results 
allow some conclusions concerning the relative impor-
tance of the gonads and adrenals to estrogen production 
in infant boys and girls. The adrenal estrogen content 
was high, and no sex difference in adrenal estrogen 
content was found. These results suggest that the adrenal 
contribution to the circulating estrogen pool is the same 
for both sexes, that adrenal secretion accounts for most 
of the basal plasma estrogen pool, and that the gonads 
are the source of the transient elevations in plasma E 2 
and E i and the sex differences found in the first year of 
life. These differences disappeared during the second 
year of life, when gonadal activity becomes quiescent for 
the remaining prepubertal period. 
It is well known that in adults the adrenals play an 
important part in the production of estrogens, especially 
E i (11-13), because they are the source of its major 
precursor, androstenedione. E i arises almost exclusively 
from extraglandular formation due principally to periph-
eral aromatization of adrenal androstenedione, and there 
seems to be no direct adrenal estrogen secretion (13). We 
found, in contrast, that in the adrenal tissue of infants, 
E i and E 2 were present in equal concentrations. Since 
the adrenal concentrations exceeded by some 100 times 
the plasma concentrations in normal infants, these es-
trogens must have been formed directly by the adrenals. 
Whether this is true at all stages of life or is just a 
peculiarity of infancy is not known, and we cannot with 
certainty exclude its being only a postmortem artefact. 
The main gonadal estrogen in adult men and women 
is E 2 (13-16). Correspondingly, we found markedly more 
E 2 than E i in infant ovaries and testes. In seven adult 
men, Leinonen (17) found mean testicular E 2 and E i 
concentrations of 4.2 ng/g (15.4 pmol/g) and 0.5 ng/g 
(1.9 pmol/g), respectively. These values approximate the 
concentrations we found in the testes of 1- to 3-month-
old boys. Comparison of the testicular estrogen concen-
trations with previous studies of testicular morphology 
(18, 19) and function (1-5) in infancy reveals a close 
relationship between testicular and plasma E 2 and tes-
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FIG. 4. Comparison of total gonadal and adrenal estrogen contents 
(organ pairs) in infant girls and boys during the first 2 yr of life. The 
bars represent the median values of the various age groups. Conversion 
factors: ng/pair X 3.699 = pmol/pair; E 2 , ng/pair X 3.671 = pmol/ 
pair. 
tosterone, Leydig cell development, and, above all, 
plasma gonadotropins. Thus, it is reasonable to assume 
that Leydig cells stimulated by gonadotropins are the 
direct or indirect source of the E 2 surge in infant boys. 
The fact that testicular E i and E 2 concentrations were 
50-100 times higher than the plasma concentrations in 
normal boys suggests direct Ex and E 2 secretion by the 
testes. This does not exclude the possibility that, as in 
adults (13), an important quantity of circulating estro-
gens arise from peripheral aromatization of androgens. 
As reported previously, the testes of 1- to 3-month-old 
boys form and secrete large amounts of androgens (2, 3), 
which may serve as substrate for the aromatase enzyme 
in extraglandular tissue. 
In the ovaries of premenopausal women, Dawood and 
Khan-Dawood (20) found 5 times more E 2 than E ^ and 
the concentrations of both estrogens varied in the differ-
ent ovarian compartments, being 10 times higher in 
corpora lutea than in stroma. The concentrations in the 
whole ovaries of infants were similar to these stromal 
levels and, in 2- to 4-month-old girls, exceeded them. 
McNatty et cd. (21) measured estrogens in follicular fluid 
throughout the menstrual cycle. In immature follicles 
smaller than 8 mm, they found estrogen concentrations 
similar to those we found in whole ovaries of 2- to 4-
month-old girls. However, as the follicles matured, the 
follicular fluid concentrations increased. 
In vitro, the infant ovary responds to gonadotropins 
by increasing steroid production (22). In patients with 
true precocious puberty, gonadotropins can cause a rapid 
increase in estrogen production, even in very young girls, 
In normal infant girls, the postnatal surge of plasma 
gonadotropins (1) obviously reaches the ovary and stim-
ulates it, as indicated by the transient elevation of plasma 
E 2 , described previously (4) and confirmed by the 
changes in ovarian morphology and estrogen content 
described herein. The ovarian growth curve peaked dur-
ing the period of high gonadotropin levels, i.e. between 1 
and 6 months of age, and the largest ovaries had the 
most advanced follicular development and, at the same 
time, the highest estrogen concentrations. Even before 
estrogens and gonadotropins could be measured in chil-
dren, Kraus and Neubecker (23) concluded that pituitary 
gonadotropins act on the infant ovary and incite follic-
ular development and estrogen synthesis. The occurrence 
of Graafian follicles in juvenile ovaries from infancy 
onward has been described as a normal finding (24-26). 
According to Polhemus (26), follicular development in-
creases after birth and is most marked at 4 months of 
age, after which it declines again. 
The parallels in the time sequence between hormonal 
and morphological changes in the hypophyseal-ovarian 
system suggest that the changes in ovarian morphology 
and function during infancy are strongly dependent on 
gonadotropin secretion. It has been suggested that in 
infant boys, transient activation of the testes is impor-
tant in promoting tubular growth and germ cell matu-
ration (3, 27). Likewise, it is conceivable that in infant 
girls, transient activation of the ovaries plays a role in 
the maturation of primordial follicles and their reduction 
in number. 
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